nivolumab,ipilimumab
bms
['nivo', '/ipi', 'check,mate,914', 'sarcoma']
dr. with an important presentation of #checkmate914 part a subgroup analyses. #asco23 while the overall trial showed no improved outcomes with the combination of nivo/ipi vs placebo, sarcomatoid, high grade, and pd-l1 positive patients seemed to derive benefit 
PGY-2 @BrighamMedRes | @USJLiban MSc '16 MD '18 | @DanaFarber Research '21 | @ASCO #IMG CoP & #JCOCCI Editorial Board | Cancer Genomics |
FCOI: https://t.co/dYsEwGGqP1